| Jubilant Pharmova Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 530019 |
NSE Symbol : JUBLPHARMA |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE700A01033 |
Div & Yield% : 0.46 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 140.87 |
Market Cap(₹Cr) : 17,147.05 |
Face Value(₹) : 1.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 745.70 | 784.70 | 810.10 | 725.73 | 2,709.50 |
| Other Income | 99.60 | 103.40 | 137.90 | 126.16 | 47.88 |
| Stock Adjustments | 6.70 | -39.00 | -3.50 | 40.61 | -55.21 |
| Total Income | 852.00 | 849.10 | 944.50 | 892.50 | 2,702.17 |
| EXPENDITURE : | |||||
| Raw Materials | 282.50 | 316.50 | 411.10 | 372.89 | 1,395.15 |
| Power and Fuel Cost | 78.00 | 68.40 | 75.40 | 62.31 | 280.40 |
| Other Manufacturing Expenses | 60.60 | 59.60 | 49.00 | 39.80 | 216.91 |
| Selling and Administration Expenses | 91.10 | 88.60 | 93.00 | 111.59 | 100.02 |
| Miscellaneous Expenses | 16.30 | 6.10 | 7.70 | 9.65 | 14.07 |
| Employee Benefit Expenses | 203.00 | 190.00 | 167.30 | 163.64 | 220.67 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 120.50 | 119.90 | 141.00 | 132.62 | 474.94 |
| Interest | 29.80 | 29.90 | 18.50 | 10.99 | 101.80 |
| Gross Profit | 90.70 | 90.00 | 122.50 | 121.63 | 373.14 |
| Depreciation | 53.10 | 48.30 | 43.20 | 36.91 | 99.97 |
| Profit Before Tax | 37.60 | 41.70 | 79.30 | 84.72 | 273.17 |
| Current Tax | 19.80 | 6.80 | 13.80 | 14.28 | 45.44 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -1.40 | 3.30 | 15.60 | -10.05 | 13.25 |
| Reported Net Profit | 19.20 | 31.60 | 49.90 | 80.49 | 214.48 |
| Extraordinary Items | -5.30 | -0.76 | 0.25 | 0.02 | -0.19 |
| Adjusted Net Profit | 24.50 | 32.36 | 49.65 | 80.47 | 214.67 |
| Adjustment below Net Profit | 3.30 | 0.00 | -0.70 | 0.81 | -212.82 |
| Profit/Loss Balance carried down | 1,075.60 | 1,123.60 | 1,154.00 | 1,152.37 | 1,153.26 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 79.60 | 79.60 | 79.60 | 79.64 | 0.00 |
| P & L Balance carried down | 1,018.50 | 1,075.60 | 1,123.60 | 1,154.03 | 1,154.92 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 500.00 | 500.00 | 500.00 | 500.00 | 500.00 |
| Dividend Per Share(Rs) | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Earnings Per Share-Unit Curr | 1.21 | 1.99 | 3.14 | 5.05 | 13.46 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 145.79 | 149.34 | 151.86 | 153.11 | 80.51 |
| Book Value(Adj)-Unit Curr | 145.79 | 149.34 | 151.86 | 153.11 | 80.51 |